CN107530359B - 脂肪组织的减少 - Google Patents

脂肪组织的减少 Download PDF

Info

Publication number
CN107530359B
CN107530359B CN201680024180.4A CN201680024180A CN107530359B CN 107530359 B CN107530359 B CN 107530359B CN 201680024180 A CN201680024180 A CN 201680024180A CN 107530359 B CN107530359 B CN 107530359B
Authority
CN
China
Prior art keywords
amount
polidocanol
formulation
pharmaceutical formulation
volume
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201680024180.4A
Other languages
English (en)
Chinese (zh)
Other versions
CN107530359A (zh
Inventor
约翰·丹尼尔·杜巴克三世
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
10x Biology Co ltd
Original Assignee
10x Biology Co ltd
John Daniel Dubuck
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 10x Biology Co ltd, John Daniel Dubuck filed Critical 10x Biology Co ltd
Priority to CN201910801669.3A priority Critical patent/CN110339159B/zh
Publication of CN107530359A publication Critical patent/CN107530359A/zh
Application granted granted Critical
Publication of CN107530359B publication Critical patent/CN107530359B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
CN201680024180.4A 2015-02-27 2016-02-24 脂肪组织的减少 Active CN107530359B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910801669.3A CN110339159B (zh) 2015-02-27 2016-02-24 脂肪组织的减少

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201562121927P 2015-02-27 2015-02-27
US62/121,927 2015-02-27
US201562165716P 2015-05-22 2015-05-22
US62/165,716 2015-05-22
US14/796,686 US9351945B1 (en) 2015-02-27 2015-07-10 Reduction of adipose tissue
US14/796,686 2015-07-10
PCT/US2016/019366 WO2016138136A1 (en) 2015-02-27 2016-02-24 Reduction of adipose tissue

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN201910801669.3A Division CN110339159B (zh) 2015-02-27 2016-02-24 脂肪组织的减少

Publications (2)

Publication Number Publication Date
CN107530359A CN107530359A (zh) 2018-01-02
CN107530359B true CN107530359B (zh) 2020-02-18

Family

ID=56027678

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201680024180.4A Active CN107530359B (zh) 2015-02-27 2016-02-24 脂肪组织的减少
CN201910801669.3A Active CN110339159B (zh) 2015-02-27 2016-02-24 脂肪组织的减少

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201910801669.3A Active CN110339159B (zh) 2015-02-27 2016-02-24 脂肪组织的减少

Country Status (9)

Country Link
US (6) US9351945B1 (enExample)
EP (2) EP3744330B1 (enExample)
JP (2) JP6566531B2 (enExample)
KR (4) KR20250156844A (enExample)
CN (2) CN107530359B (enExample)
AU (1) AU2016222802B2 (enExample)
CA (1) CA2977960C (enExample)
ES (2) ES2970312T3 (enExample)
WO (1) WO2016138136A1 (enExample)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8444562B2 (en) 2004-10-06 2013-05-21 Guided Therapy Systems, Llc System and method for treating muscle, tendon, ligament and cartilage tissue
US8535228B2 (en) 2004-10-06 2013-09-17 Guided Therapy Systems, Llc Method and system for noninvasive face lifts and deep tissue tightening
US10864385B2 (en) 2004-09-24 2020-12-15 Guided Therapy Systems, Llc Rejuvenating skin by heating tissue for cosmetic treatment of the face and body
US9694212B2 (en) 2004-10-06 2017-07-04 Guided Therapy Systems, Llc Method and system for ultrasound treatment of skin
US8690778B2 (en) 2004-10-06 2014-04-08 Guided Therapy Systems, Llc Energy-based tissue tightening
US11235179B2 (en) 2004-10-06 2022-02-01 Guided Therapy Systems, Llc Energy based skin gland treatment
US8133180B2 (en) 2004-10-06 2012-03-13 Guided Therapy Systems, L.L.C. Method and system for treating cellulite
US11883688B2 (en) 2004-10-06 2024-01-30 Guided Therapy Systems, Llc Energy based fat reduction
US11724133B2 (en) 2004-10-07 2023-08-15 Guided Therapy Systems, Llc Ultrasound probe for treatment of skin
US11207548B2 (en) 2004-10-07 2021-12-28 Guided Therapy Systems, L.L.C. Ultrasound probe for treating skin laxity
US12102473B2 (en) 2008-06-06 2024-10-01 Ulthera, Inc. Systems for ultrasound treatment
US10537304B2 (en) 2008-06-06 2020-01-21 Ulthera, Inc. Hand wand for ultrasonic cosmetic treatment and imaging
EP2382010A4 (en) 2008-12-24 2014-05-14 Guided Therapy Systems Llc METHOD AND SYSTEMS FOR FAT REDUCTION AND / OR TREATMENT OF CELLULITE
WO2011075676A2 (en) 2009-12-18 2011-06-23 Knowlton Edward W A skin treatment and drug delivery device
US11103275B2 (en) 2010-12-17 2021-08-31 Srgi Holdings, Llc Pixel array medical systems, devices and methods
US10967162B2 (en) 2010-12-17 2021-04-06 Srgi Holdings, Llc Systems, devices and methods for fractional resection, fractional skin grafting, fractional scar reduction and fractional tattoo removal
US10736653B2 (en) 2013-12-06 2020-08-11 Srgi Holdings, Llc Pixel array medical systems, devices and methods
US11278309B2 (en) 2010-12-17 2022-03-22 Srgi Holdings, Llc Pixel array medical systems, devices and methods
US10856900B2 (en) 2010-12-17 2020-12-08 Srgi Holdings, Llc Pixel array medical systems, devices and methods
US10368904B2 (en) 2013-12-06 2019-08-06 Srgi Holdings, Llc Pixel array medical systems, devices and methods
US10702684B2 (en) 2010-12-17 2020-07-07 Srgi Holdings, Llc Systems, devices and methods for fractional resection, fractional skin grafting, fractional scar reduction and fractional tattoo removal
US11000310B2 (en) 2010-12-17 2021-05-11 Srgi Holdings, Llc Pixel array medical systems, devices and methods
CN204017181U (zh) 2013-03-08 2014-12-17 奥赛拉公司 美学成像与处理系统、多焦点处理系统和执行美容过程的系统
ES2827049T3 (es) 2013-10-02 2021-05-19 Srgi Holdings Llc Dispositivos médicos de conjunto de píxeles
MX2016004331A (es) 2013-10-02 2016-11-10 Srgi Holdings Llc Dispositivos y metodos medicos de distribucion de pixeles.
US11937846B2 (en) 2013-12-06 2024-03-26 Srgi Holdings Llc Pixel array medical systems, devices and methods
US11229452B2 (en) 2013-12-06 2022-01-25 Srgi Holdings, Llc Pixel array medical systems, devices and methods
JP2017513587A (ja) 2014-04-18 2017-06-01 ウルセラ インコーポレイテッド 帯状変換器超音波治療
JP6805157B2 (ja) 2015-02-05 2020-12-23 エスアールジーアイ ホールディングス エルエルシーＳｒｇｉ Ｈｏｌｄｉｎｇｓ Ｌｌｃ ピクセルアレイ医療システム、デバイスおよび方法
US9351945B1 (en) * 2015-02-27 2016-05-31 John Daniel Dobak, III Reduction of adipose tissue
US11751903B2 (en) 2015-08-31 2023-09-12 Srgi Holdings, Llc Pixel array medical systems, devices and methods
US11490952B2 (en) 2015-08-31 2022-11-08 Srgi Holdings, Llc Pixel array medical devices and methods
RU2720661C2 (ru) 2016-01-18 2020-05-12 Ультера, Инк. Компактное ультразвуковое устройство, содержащее кольцеобразную ультразвуковую матрицу, электрически соединенную по периферии с гибкой печатной платой, и способ сборки такого устройства
US11564706B2 (en) 2019-10-28 2023-01-31 Srgi Holdings, Llc Pixel array medical systems, devices and methods
EP3251654A1 (de) * 2016-05-30 2017-12-06 Chemische Fabrik Kreussler & Co. Gmbh Nichtionische tenside zur reduktion von fettgewebe
RU2748788C2 (ru) 2016-08-16 2021-05-31 Ультера, Инк. Системы и способы для косметической ультразвуковой обработки кожи
WO2018077825A1 (en) * 2016-10-28 2018-05-03 Merz Pharma Gmbh & Co. Kgaa Treatment of gynoid lipodystrophy
WO2020086915A2 (en) 2017-05-03 2020-04-30 Srgi Holdings Llc Handed spiral slotted scalpet array
WO2018217479A2 (en) * 2017-05-11 2018-11-29 Srgi Holdings, Llc Systems, devices and methods for fractional resection, fractional skin grafting, fractional scar reduction and fractional tattoo removal
TWI883390B (zh) 2018-01-26 2025-05-11 美商奧賽拉公司 用於多個維度中的同時多聚焦超音治療的系統和方法
WO2019164836A1 (en) * 2018-02-20 2019-08-29 Ulthera, Inc. Systems and methods for combined cosmetic treatment of cellulite with ultrasound
IT201800006109A1 (it) 2018-06-07 2019-12-07 Polidocanolo per uso come immunomodulatore
US11986443B2 (en) * 2018-10-16 2024-05-21 Polithera, Inc. Alcohol-based compositions and uses thereof
EP3713551B1 (en) 2018-10-16 2023-06-07 Polithera, Inc. Alcohol-based compositions and uses thereof
US20210000760A1 (en) * 2018-10-16 2021-01-07 Polithera, Inc. Alcohol-based compositions and uses thereof
AU2019385902B2 (en) 2018-11-30 2025-07-10 Ulthera, Inc. Systems and methods for enhancing efficacy of ultrasound treatment
BR112022000062A2 (pt) 2019-07-15 2022-06-07 Ulthera Inc Sistemas e métodos para medir elasticidade com imagem de ondas de cisalhamento multifocais de ultrassom em múltiplas dimensões
KR102937196B1 (ko) 2020-07-09 2026-03-09 주식회사 엘지에너지솔루션 통신 시스템 및 방법
EP3973951A1 (en) * 2020-09-23 2022-03-30 Polithera, Inc. Alcohol-based compositions and uses thereof
WO2025101049A1 (ko) * 2023-11-07 2025-05-15 (주)시지바이오 지방분해주사제 조성물
WO2025122498A1 (en) * 2023-12-04 2025-06-12 10Xbio, Llc Reduction of adipose tissue

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1739550A (zh) * 2005-09-16 2006-03-01 陕西天宇制药有限公司 聚桂醇注射液及其制备方法
WO2008113421A1 (de) * 2007-03-19 2008-09-25 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Neue pharmazeutische zusammensetzungen für die lipolyse und verfahren zu deren herstellung
CN101594873A (zh) * 2006-10-17 2009-12-02 利特拉公司 用于治疗脂肪组织，皮肤组织和病症，和肌肉组织的配方
CN102198089A (zh) * 2011-05-19 2011-09-28 陕西天宇制药有限公司 聚桂醇注射液作为治疗内痔药物的应用
CN103191146A (zh) * 2013-04-22 2013-07-10 福建医科大学附属协和医院 一种高效无痛的肿瘤局部消融治疗药物

Family Cites Families (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4267169A (en) * 1978-07-22 1981-05-12 Toko Yakuhin Kogyo Kabushiki Kaisha Novel preparation of clotrimazole
US5164320A (en) * 1990-03-05 1992-11-17 Becton, Dickinson And Company Method for lysing hard liposomes using polyethyleneglycol mono-n-alkyl ethers
JPH07500113A (ja) 1991-10-16 1995-01-05 リチャードソン、ビックス、インコーポレーテッド 薬物の改善された局所送達用の高皮膚浸透系
BR9306816A (pt) 1992-07-28 1998-12-08 Procter & Gamble Composição farmaceutica para uso tópico contendo um polímero catiônico reticulado e um eter alcoxilado
ES2068151B1 (es) 1993-06-23 1995-11-16 Cabrera Garrido Juan Microespuma inyectable para esclerosis.
US5681552A (en) 1995-05-23 1997-10-28 The Mennen Company Clear cosmetic stick composition containing a combination of anionic and non-ionic surfactants
ATE413415T1 (de) 1996-09-19 2008-11-15 Univ Michigan Polymere enthaltend polysaccharide wie alginate oder modifizierte alginate
JP5062708B2 (ja) * 1998-02-24 2012-10-31 株式会社マンダム 防腐殺菌剤及び人体施用組成物
US7494488B2 (en) 1998-05-28 2009-02-24 Pearl Technology Holdings, Llc Facial tissue strengthening and tightening device and methods
US6284234B1 (en) * 1998-08-04 2001-09-04 Johnson & Johnson Consumer Companies, Inc. Topical delivery systems for active agents
CH693625A5 (it) 1999-02-18 2003-11-28 Inpharma Sa Composizioni farmaceutiche contenenti composti ad attività promotrice di assorbimento di principi attivi.
GB9912356D0 (en) 1999-05-26 1999-07-28 Btg Int Ltd Generation of microfoam
GB0028692D0 (en) 2000-11-24 2001-01-10 Btg Int Ltd Generation of therapeutic microform
DE50101401D1 (de) 2001-06-11 2004-03-04 Filtertek Bv Kombinationsfilter-Anordnung
US20030216364A1 (en) 2001-08-13 2003-11-20 Johnson Keith Arthur Dermatological Formulation
DE10158199A1 (de) * 2001-11-27 2003-06-18 Beiersdorf Ag Juckreizstillende kosmetische und dermatologische Zubereitungen
JP4387639B2 (ja) 2002-07-16 2009-12-16 久光製薬株式会社 経皮吸収製剤
WO2004051549A2 (en) 2002-12-02 2004-06-17 Allergan, Inc. Active agent delivery method
GB0307869D0 (en) 2003-04-04 2003-05-14 Novartis Ag Pharmaceutical composition
US7439241B2 (en) * 2003-05-27 2008-10-21 Galderma Laboratories, Inc. Compounds, formulations, and methods for treating or preventing rosacea
US20080069779A1 (en) 2003-08-04 2008-03-20 Foamix Ltd. Foamable vehicle and vitamin and flavonoid pharmaceutical compositions thereof
GB0321210D0 (en) 2003-09-10 2003-10-08 Btg Int Ltd Apparatus and method for dispensing foam
DE10349979B4 (de) 2003-10-24 2006-05-18 Sanofi-Aventis Deutschland Gmbh Medikamentöse gezielte lokale Lipolyse
US20050089555A1 (en) 2003-10-24 2005-04-28 Aventis Pharma Deutschland Gmbh Medicinal targeted local lipolysis
CA2536041A1 (en) 2003-11-10 2005-05-26 Angiotech International Ag Medical implants and fibrosis-inducing agents
AU2004290957A1 (en) * 2003-11-17 2005-06-02 Btg International Limited Methods of preparing a foam comprising a sclerosing agent
US20050143347A1 (en) 2003-12-22 2005-06-30 Aventis Pharma Deutschland Gmbh Medicinal lipolysis of accumulations of fat
EP1706148A2 (en) 2004-01-14 2006-10-04 Gilead Sciences, Inc. Lipid-based dispersions useful for drug delivery
US7754230B2 (en) 2004-05-19 2010-07-13 The Regents Of The University Of California Methods and related compositions for reduction of fat
ES2372499T3 (es) 2004-05-19 2012-01-20 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Uso de un detergente para la eliminación no quirúrgica de grasa.
US20060127468A1 (en) 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
US7727537B2 (en) 2005-02-14 2010-06-01 Dpm Therapeutics Corp. Stabilized compositions for topical administration and methods of making same
WO2006133876A1 (en) * 2005-06-17 2006-12-21 Dsm Ip Assets B.V. Use of pyrimidine derivatives for cosmetic purposes
DE102005037844A1 (de) 2005-08-04 2007-04-05 Intendis Gmbh Wasserfreies Mehr-Phasen-Gel-System
DE102005039579B4 (de) 2005-08-19 2022-06-30 Magforce Ag Verfahren zur Einschleusung von therapeutischen Substanzen in Zellen
UA97234C2 (ru) * 2005-11-01 2012-01-25 Уайєт Раствор хлорида натрия для восстановления влагосодержания композиции лиофилизированного фактора ix
NZ567601A (en) 2005-11-30 2010-12-24 Generex Pharm Inc Orally absorbed pharmaceutical formulation and method of administration
PL2077830T3 (pl) * 2006-10-17 2013-04-30 Lithera Inc Sposoby, kompozycje i formulacje do leczenia orbitopatii tarczycowej
US20080206155A1 (en) 2006-11-14 2008-08-28 Foamix Ltd. Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses
GB0623838D0 (en) 2006-11-29 2007-01-10 Malvern Cosmeceutics Ltd Novel compositions
EP1946746A1 (en) 2007-01-17 2008-07-23 Merz Pharma GmbH & Co. KGaA Particulate aqueous system for the preparation of a formulation for the treatment of adipose diseases
EP1970051A1 (en) 2007-03-14 2008-09-17 Merz Pharma GmbH & Co.KGaA Use of an aqueous micro-emulsion for the preparation of a formulation for the treatment of adipose diseases
BRPI0806773A2 (pt) 2007-01-17 2011-09-13 Merz Pharma Gmbh & Co Kgaa uso de um tensoativo para o preparo de uma formulação para o tratamento de doenças do tecido adiposo
MX2009012273A (es) 2007-05-18 2010-04-09 Tti Ellebeau Inc Dispositivos de suministro transd?rmico que aseguran la liberaci?n mejorada de un principio activo a trav?s de una interfaz biol?gica.
US20080294072A1 (en) 2007-05-24 2008-11-27 Crutchfield Dermatology Mesotherapy with ultrasound
US8242294B2 (en) 2007-06-19 2012-08-14 Kythera Biopharmaceuticals, Inc. Synthetic bile acid compositions and methods
JOP20180077A1 (ar) 2007-06-19 2019-01-30 Kythera Biopharmaceuticals Inc تركيبات وطرق لحمض صفراوي تخليقي
WO2009009406A1 (en) * 2007-07-06 2009-01-15 Smithkline Beecham Corporation Antibody formulations
US20090202467A1 (en) 2008-02-08 2009-08-13 Bock Richard W Sclerotherapy for varicose veins
KR20090116981A (ko) * 2008-05-08 2009-11-12 (주)와이즈덤레버러토리 석류피 추출물을 유효성분으로 포함하는 면역반응 조절을통한 탈모 방지 및 치료용 조성물
TWM351548U (en) 2008-07-17 2009-02-21 Wistron Corp Oscillating power generator with a ratchet mechanism
CA2741334A1 (en) 2008-10-22 2010-04-29 Allergan, Inc. Clinical assessment scales and methods
AU2010217190B2 (en) 2009-02-25 2012-10-25 Mayne Pharma Llc Topical foam composition
US8101593B2 (en) 2009-03-03 2012-01-24 Kythera Biopharmaceuticals, Inc. Formulations of deoxycholic acid and salts thereof
ES2530049T3 (es) 2009-05-18 2015-02-26 Sigmoid Pharma Limited Composición que comprende gotas de aceite
CN105919832A (zh) 2010-06-11 2016-09-07 宝洁公司 用于处理皮肤的组合物
US20120016347A1 (en) 2010-07-13 2012-01-19 Shipp John I Seroma Control for Surgical Patients
EP2593093A1 (en) 2010-07-16 2013-05-22 Merz Pharma GmbH & Co. KGaA Use of a cationic amphiphilic drug for the preparation of a formulation for the reduction of subcutaneous adipose tissue
AU2012222380A1 (en) 2011-03-01 2013-08-22 Merz Pharma Gmbh & Co. Kgaa Composition comprising peroxisome proliferator-activated receptor-gamma (PPAR)
US9241921B2 (en) 2011-05-02 2016-01-26 Pankaj Modi Photosensitizer composition for treating skin disorders
AU2012344297A1 (en) 2011-11-30 2014-04-24 Merz Pharma Gmbh & Co. Kgaa Use of pegylated alcohols for the treatment of actinic keratosis
WO2014164815A2 (en) * 2013-03-12 2014-10-09 Allergan, Inc. Adipose tissue combinations, devices, and uses thereof
WO2014193818A1 (en) * 2013-05-28 2014-12-04 Momenta Pharmaceuticals, Inc. Pharmaceutical compositions
US20140356968A1 (en) * 2013-06-04 2014-12-04 Therapeutic Proteins International, LLC Methods for comparing a structure of a first biomolecule and a second biomolecule
US9351945B1 (en) 2015-02-27 2016-05-31 John Daniel Dobak, III Reduction of adipose tissue
EP3251654A1 (de) * 2016-05-30 2017-12-06 Chemische Fabrik Kreussler & Co. Gmbh Nichtionische tenside zur reduktion von fettgewebe

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1739550A (zh) * 2005-09-16 2006-03-01 陕西天宇制药有限公司 聚桂醇注射液及其制备方法
CN101594873A (zh) * 2006-10-17 2009-12-02 利特拉公司 用于治疗脂肪组织，皮肤组织和病症，和肌肉组织的配方
WO2008113421A1 (de) * 2007-03-19 2008-09-25 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Neue pharmazeutische zusammensetzungen für die lipolyse und verfahren zu deren herstellung
CN102198089A (zh) * 2011-05-19 2011-09-28 陕西天宇制药有限公司 聚桂醇注射液作为治疗内痔药物的应用
CN103191146A (zh) * 2013-04-22 2013-07-10 福建医科大学附属协和医院 一种高效无痛的肿瘤局部消融治疗药物

Also Published As

Publication number Publication date
US20180228741A1 (en) 2018-08-16
JP2018506575A (ja) 2018-03-08
US10485767B2 (en) 2019-11-26
EP3261646B1 (en) 2020-07-22
EP3744330A1 (en) 2020-12-02
KR102266369B1 (ko) 2021-06-16
US20210378984A1 (en) 2021-12-09
CA2977960C (en) 2022-11-15
ES2970312T3 (es) 2024-05-28
AU2016222802B2 (en) 2020-11-05
WO2016138136A1 (en) 2016-09-01
CN107530359A (zh) 2018-01-02
KR20230128392A (ko) 2023-09-04
AU2016222802A1 (en) 2017-10-12
KR20200084903A (ko) 2020-07-13
KR20170139003A (ko) 2017-12-18
CA2977960A1 (en) 2016-09-01
JP2019218353A (ja) 2019-12-26
CN110339159A (zh) 2019-10-18
EP3261646A4 (en) 2018-11-14
JP6566531B2 (ja) 2019-08-28
KR20250156844A (ko) 2025-11-03
JP6920379B2 (ja) 2021-08-18
US20160310444A1 (en) 2016-10-27
EP3744330B1 (en) 2023-11-22
US11065210B2 (en) 2021-07-20
US9351945B1 (en) 2016-05-31
US20250073181A1 (en) 2025-03-06
ES2819148T3 (es) 2021-04-15
US9844520B2 (en) 2017-12-19
CN110339159B (zh) 2023-01-17
US12133836B2 (en) 2024-11-05
EP3261646A1 (en) 2018-01-03
US20200085763A1 (en) 2020-03-19

Similar Documents

Publication Publication Date Title
CN107530359B (zh) 脂肪组织的减少
ES2727269T3 (es) Métodos y composiciones para la reducción de la grasa corporal y adipocitos
JP2023179467A (ja) 投与および処置の方法
CA2761744C (en) Methods for administration and formulations for the treatment of regional adipose tissue
KR20140025312A (ko) 지방증 및 윤곽 팽창의 미용적 치료를 위한 선택적인, 친유성, 및 지속성 베타 작용제 단일치료 제형 및 방법
JP7124248B1 (ja) エピナスチン又はその塩を含有する塗布投与用医薬組成物
HK40014982A (en) Reduction of adipose tissue
HK40014982B (en) Reduction of adipose tissue
JP7124234B2 (ja) フェノルドパムの安定な局所用組成物
WO2025122498A1 (en) Reduction of adipose tissue
HK40097614A (en) Pharmaceutical composition for topical administration containing epinastine or salt thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
CB02 Change of applicant information

Address after: California, USA

Applicant after: John Daniel dubak III

Address before: California, USA

Applicant before: John Daniel Dubuck

CB02 Change of applicant information
CB03 Change of inventor or designer information

Inventor after: John Daniel dubak III

Inventor before: John Daniel Dubuck

CB03 Change of inventor or designer information
TA01 Transfer of patent application right

Effective date of registration: 20191230

Address after: California, USA

Applicant after: 10x biology Co.,Ltd.

Address before: California, USA

Applicant before: John Daniel dubak III

TA01 Transfer of patent application right
GR01 Patent grant
GR01 Patent grant